Management of perimenopausal and menopausal symptoms.
Duralde ER, Sobel TH, Manson JE.
BMJ. 2023 Aug 8;382:e072612. doi: 10.1136/bmj-2022-072612.
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R.
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
Testosterone therapy for transgender men.
Irwig MS.
Lancet Diabetes Endocrinol. 2017 Apr;5(4):301-311. doi: 10.1016/S2213-8587(16)00036-X. Epub 2016 Apr 12.
Sexuality and Infertility.
Kelley EL, Kingsberg SA.
Obstet Gynecol Clin North Am. 2024 Jun;51(2):311-322. doi: 10.1016/j.ogc.2024.02.005. Epub 2024 Apr 4.
Bremelanotide for Treatment of Female Hypoactive Sexual Desire.
Edinoff AN, Sanders NM, Lewis KB, Apgar TL, Cornett EM, Kaye AM, Kaye AD.
Neurol Int. 2022 Jan 4;14(1):75-88. doi: 10.3390/neurolint14010006.
Sexual desire after olfactory loss: Quantitative and qualitative reports of patients with smell disorders.
Schäfer L, Mehler L, Hähner A, Walliczek U, Hummel T, Croy I.
Physiol Behav. 2019 Mar 15;201:64-69. doi: 10.1016/j.physbeh.2018.12.020. Epub 2018 Dec 18.
Sexuality and menopause.
Sarrel PM.
Obstet Gynecol. 1990 Apr;75(4 Suppl):26S-30S; discussion 31S-35S.
The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS; Dutasteride Alopecia Research Team.
J Am Acad Dermatol. 2006 Dec;55(6):1014-23. doi: 10.1016/j.jaad.2006.05.007.
Androgens and menopause.
Shulman LP.
Minerva Ginecol. 2009 Dec;61(6):491-7.
Weibliche Libido - eine Frage der Hormone?
Leeners B.
Praxis (Bern 1994). 2013 Apr 15;102(9):523-8. doi: 10.1024/1661-8157/a001276.
